|
G |
Ddo |
D-aspartate oxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16525061 |
|
NCBI chr20:44,090,823...44,109,962
|
|
G |
Prl |
prolactin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10084644 PMID:15677431 |
|
NCBI chr17:38,287,355...38,298,234
|
|
G |
Ptger1 |
prostaglandin E receptor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18726914 |
|
NCBI chr19:24,470,258...24,473,687
|
|
G |
Ptger2 |
prostaglandin E receptor 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18726914 |
|
NCBI chr15:18,215,013...18,228,714
|
|
G |
Ptger4 |
prostaglandin E receptor 4 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:18726914 |
|
NCBI chr 2:56,061,699...56,074,594
|
|
|
G |
Adamtsl2 |
ADAMTS-like 2 |
|
ISS |
|
MouseDO |
|
|
NCBI chr 3:10,397,774...10,434,557
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
treatment |
IDA |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:23698784 |
RGD:7244246 |
NCBI chr20:4,152,758...4,155,956
|
|
G |
Agt |
angiotensinogen |
treatment |
IDA |
|
RGD |
PMID:17616753 |
RGD:8548892 |
NCBI chr19:69,426,540...69,447,017
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
treatment |
IDA |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:21235725 |
RGD:10053666 |
NCBI chr 6:137,534,810...137,555,131
|
|
G |
Bad |
BCL2-associated agonist of cell death |
treatment |
IDA |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:21235725 |
RGD:10053666 |
NCBI chr 1:213,562,719...213,572,034
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:21235725 |
RGD:10053666 |
NCBI chr 1:105,076,472...105,081,906
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IDA ISO IEP |
CTD Direct Evidence: marker/mechanism associated with Diabetes Mellitus, Experimental |
CTD RGD |
PMID:12394778 PMID:12394778 PMID:21235725 |
RGD:1579980, RGD:10053666 |
NCBI chr13:23,204,464...23,366,900
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
|
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12394778 PMID:12394778 |
RGD:1579980 |
NCBI chr 3:161,713,777...161,764,844
|
|
G |
Casp3 |
caspase 3 |
treatment |
IEP |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:21235725 |
RGD:10053666 |
NCBI chr16:52,395,539...52,413,794
|
|
G |
Ccnd1 |
cyclin D1 |
|
IEP |
mRNA:decreased expression:penis erectile tissue |
RGD |
PMID:17137605 |
RGD:1625408 |
NCBI chr 1:209,518,288...209,527,986
|
|
G |
Ccnd2 |
cyclin D2 |
|
IEP |
associated with Diabetes Mellitus, Experimental;mRNA:decreased expression:penis |
RGD |
PMID:18068478 |
RGD:2289159 |
NCBI chr 4:161,653,048...161,675,422
|
|
G |
Cfl1 |
cofilin 1 |
treatment |
IEP |
protein:increased phosphorylation:corpus cavernosum penis (rat) |
RGD |
PMID:25923835 PMID:25444982 |
RGD:11568706, RGD:11570410 |
NCBI chr 1:212,227,124...212,230,656
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
IMP |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:17850365 |
RGD:2314634 |
NCBI chr 5:53,204,867...53,230,396
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
treatment |
IMP |
|
RGD |
PMID:17433082 |
RGD:13207433 |
NCBI chr12:46,945,291...46,976,867
|
|
G |
Edn1 |
endothelin 1 |
|
IEP ISO |
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12002441 PMID:17420087 |
RGD:2292142 |
NCBI chr17:22,660,799...22,666,687
|
|
G |
Ednra |
endothelin receptor type A |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18823320 PMID:17420087 |
RGD:2292142 |
NCBI chr19:47,137,360...47,207,961
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
|
IEP |
associated with hypercholesterolemia;mRNA:increased expression:penis erectile tissue |
RGD |
PMID:17137605 |
RGD:1625408 |
NCBI chr 2:93,488,251...93,492,961
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:15758817 |
RGD:2315866 |
NCBI chr 2:122,164,454...122,218,796
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
|
IEP |
mRNA, protein:decreased expression:corpus cavernosum penis |
RGD |
PMID:17146929 |
RGD:8662385 |
NCBI chr20:36,302,490...36,315,010
|
|
G |
Grin3a |
glutamate ionotropic receptor NMDA type subunit 3A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19295509 |
|
NCBI chr 5:64,006,847...64,206,408
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
|
IMP |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:30226217 |
RGD:13792691 |
NCBI chr 1:211,010,259...211,031,013
|
|
G |
Hdac3 |
histone deacetylase 3 |
|
IEP |
protein:increased expression:penis: |
RGD |
PMID:24636283 |
RGD:9590194 |
NCBI chr18:29,770,637...29,789,850
|
|
G |
Hdac4 |
histone deacetylase 4 |
|
ISO |
protein:increased expression:penis: |
RGD |
PMID:24636283 |
RGD:9590194 |
NCBI chr 9:99,950,972...100,200,994
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
treatment |
IMP IEP |
mRNA, protein:increased expression:penis |
RGD |
PMID:24576658 PMID:21595839 |
RGD:10402763, RGD:10402765 |
NCBI chr14:86,270,208...86,277,944
|
|
G |
Il6 |
interleukin 6 |
treatment |
IMP IEP |
associated with Diabetes Mellitus, Type 2 |
RGD |
PMID:21492407 PMID:24467772 |
RGD:10402827, RGD:9495931 |
NCBI chr 4:5,889,999...5,894,575
|
|
G |
Kdr |
kinase insert domain receptor |
|
IEP |
|
RGD |
PMID:16422887 |
RGD:5684417 |
NCBI chr14:32,572,031...32,615,204
|
|
G |
Mcam |
melanoma cell adhesion molecule |
|
IEP |
protein:decreased expression:penis erectile tissue |
RGD |
PMID:24023647 |
RGD:7364777 |
NCBI chr 8:44,479,391...44,487,575
|
|
G |
Nos1 |
nitric oxide synthase 1 |
treatment |
IDA IEP |
associated with Diabetes Mellitus, Experimental associated with Urethral Obstruction;protein:decreased expression:penis erectile tissue |
RGD |
PMID:23698784 PMID:23522997 PMID:23535456 |
RGD:7244246, RGD:7257657, RGD:7257656 |
NCBI chr12:44,276,011...44,456,371
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
IEP |
associated with Diabetes Mellitus, Experimental;protein:increased expression:penis |
RGD |
PMID:19554009 |
RGD:2313212 |
NCBI chr10:64,313,335...64,349,221
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
IEP ISO |
associated with Cocaine-Related Disorders;protein:decreased expression:penis CTD Direct Evidence: marker/mechanism|therapeutic associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:decreased expression, decreased activity |
CTD RGD |
PMID:12002441 PMID:17071732 PMID:17420087 PMID:29260891 PMID:20807325 |
RGD:2292142, RGD:13504711, RGD:4891999 |
NCBI chr 4:11,686,088...11,706,604
|
|
G |
P2ry1 |
purinergic receptor P2Y1 |
|
IDA |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:19303093 |
RGD:2315809 |
NCBI chr 2:145,241,975...145,248,186
|
|
G |
P2ry2 |
purinergic receptor P2Y2 |
|
IDA |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:19303093 |
RGD:2315809 |
NCBI chr 1:164,764,119...164,779,578
|
|
G |
Pde5a |
phosphodiesterase 5A |
|
IMP |
associated with Hypercholesterolemia associated with Diabetes Mellitus, Experimental |
RGD |
PMID:15920460 PMID:15578039 PMID:15667904 |
RGD:2314519, RGD:2314521, RGD:2314520 |
NCBI chr 2:210,858,515...211,003,480
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
|
IEP |
associated with Diabetes Mellitus, Experimental;protein:decreased expression:penis erectile tissue |
RGD |
PMID:17355372 |
RGD:7775062 |
NCBI chr 1:237,818,950...239,052,184
|
|
G |
Prl |
prolactin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:387166 PMID:4001434 PMID:7878608 PMID:8845563 PMID:15829128 |
|
NCBI chr17:38,287,355...38,298,234
|
|
G |
Shbg |
sex hormone binding globulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17961146 |
|
NCBI chr10:54,332,939...54,350,409
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
IEP |
associated with Diabetes Mellitus, Type 2 |
RGD |
PMID:24467772 |
RGD:9495931 |
NCBI chr20:25,305,953...25,328,000
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
|
IEP |
associated with Diabetes Mellitus, Experimental;protein:increased expression:penis |
RGD |
PMID:18778311 PMID:27051243 |
RGD:2306738, RGD:14995446 |
NCBI chr 1:90,324,312...90,340,627
|
|
G |
Thbd |
thrombomodulin |
|
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:plasma |
RGD |
PMID:11596671 |
RGD:2312459 |
NCBI chr 3:156,316,526...156,320,178
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
IEP |
associated with Diabetes Mellitus, Type 2 |
RGD |
PMID:24467772 |
RGD:9495931 |
NCBI chr20:3,626,685...3,629,303
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12002441 |
|
NCBI chr 9:22,452,854...22,468,194
|
|
G |
Vip |
vasoactive intestinal peptide |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10233493 |
|
NCBI chr 1:44,470,232...44,478,561
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
susceptibility |
ISO |
associated with Prostatic Neoplasms;DNA:polymorphism: :p.R280H |
RGD |
PMID:18582155 |
RGD:2302570 |
NCBI chr 1:89,268,721...89,296,619
|
|
|
G |
Angpt2 |
angiopoietin 2 |
|
IEP |
associated with Hypercholesterolemia; mRNA, protein:decreased expression:cavernous body of penis (rat) |
RGD |
PMID:16750245 |
RGD:2314210 |
NCBI chr16:71,088,364...71,138,805
|
|
G |
Apod |
apolipoprotein D |
|
IEP |
mRNA:increased expression:penis erectile tissue |
RGD |
PMID:11444882 |
RGD:2311196 |
NCBI chr11:82,936,216...82,957,264
|
|
G |
Pde5a |
phosphodiesterase 5A |
|
IMP |
|
RGD |
PMID:17287493 |
RGD:2314469 |
NCBI chr 2:210,858,515...211,003,480
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
|
ISO |
protein:increased expression:penis erectile tissue |
RGD |
PMID:14718046 |
RGD:1601627 |
NCBI chr 8:124,672,677...124,761,741
|
|